(0)

DIA会员及用户请点击登录

登录

忘记用户 ID？ or 忘记密码？

Not a Member?

创建账户并加入。

Menu 返回 Committee

Meet the Program Commitee for 2026!

项目委员会

  • Representative Invited
    Representative Invited • FDA, United States
  • Sanghita Bhattacharya, PhD
    Sanghita Bhattacharya, PhD • Director Data Science Global Function
    Johnson & Johnson Innovative Medicine, United States
  • Asia Blackwell
    Asia Blackwell • Consumer Safety Officer, CBER
    FDA, United States
  • Tywnia Brewton
    Tywnia Brewton • Executive Director, Human Resources
    Astellas , United States
  • James Buchanan, PharmD
    James Buchanan, PharmD • President
    Covilance LLC, United States
  • Mandy Kaur Budwal-Jagait, MSc
    Mandy Kaur Budwal-Jagait, MSc • Head of GCP
    Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
  • Meghana Chalasani, MHA
    Meghana Chalasani, MHA • Associate Director for Clinical Trial Innovation, Office of New Drugs, CDER
    FDA, United States
  • Joan Chambers
    Joan Chambers • Independent Senior Consultant
    Tufts Center For the Study of Drug Development, United States
  • Rachel Chasse, MS
    Rachel Chasse, MS • Associate Director, Digital Science Strategy
    AbbVie, United States
  • Monica Chiaramonte, PhD
    Monica Chiaramonte, PhD • Director, Clinical Regulatory Writing
    AstraZeneca Pharmaceuticals LP, United States
  • Christine Colvis, PhD
    Christine Colvis, PhD • Director, Drug Development Partnership Programs
    National Center for Advancing Translational Sciences (NCATS), United States
  • Karen Correa, PhD
    Karen Correa, PhD • Vice President, Clinical Development Operations
    Boehringer Ingelheim, United States
  • Solange Corriol-Rohou, DrMed, MD, PhD
    Solange Corriol-Rohou, DrMed, MD, PhD •
    SCR Consulting, France
  • Stephanie Y. Crawford, PhD, MPH, MS
    Stephanie Y. Crawford, PhD, MPH, MS • Professor, Pharmacy Systems, Outcomes and Policy
    University of Illinois at Chicago, United States
  • Alysha Croker, PhD
    Alysha Croker, PhD • Director, Strategic and Horizontal Policy
    Health Canada, Canada
  • Matthew Curin, PharmD
    Matthew Curin, PharmD • Sr. Dir, Head of Program Management, Therapeutic Dermatology
    Galderma, United States
  • Representative Invited
    Representative Invited • FDA, United States
  • Victoria DiBiaso, BSN, MPH, RN
    Victoria DiBiaso, BSN, MPH, RN • Global Head, Patient Informed Development and Health Value Translation
    Sanofi, France
  • Megan Doyle, JD, MPH
    Megan Doyle, JD, MPH • Associate Vice President, Assistant General Counsel - Diagnostics
    Eli Lilly & Company, United States
  • Nancy Dreyer, PhD, MPH, FISPE
    Nancy Dreyer, PhD, MPH, FISPE • Founder
    Dreyer Strategies LLC, United States
  • Joseph Dustin
    Joseph Dustin • Founder and Principal
    Dauntless Eclinical Strategies, United States
  • Jennifer Emerson, PhD, MPH, RN, PMP
    Jennifer Emerson, PhD, MPH, RN, PMP • Head Quality Analytics & Risk Management
    Boehringer Ingelheim, Germany
  • Andrew Emmett, MPH
    Andrew Emmett, MPH • VP, Global Regulatory Policy and Global Intelligence
    Pfizer Inc, United States
  • Celeste Frankenfeld Lamm
    Celeste Frankenfeld Lamm • Senior Director, Global Regulatory Affairs – CMC
    Merck Sharp & Dohme LLC , United States
  • Danielle Friend Economo, PhD
    Danielle Friend Economo, PhD • Senior Director, US Head Regulatory Policy and Intelligence
    Johnson & Johnson Innovative Medicine, United States
  • David Fryrear, MS
    David Fryrear, MS • Chief Quality Officer
    Astellas, United States
  • Cheryl Grandinetti, PharmD
    Cheryl Grandinetti, PharmD • Associate Director for Clinical Policy, CDER/OC/OSI/DCCE
    FDA, United States
  • Courtney Granville, PhD, MPH
    Courtney Granville, PhD, MPH •
    United States
  • Lani Hashimoto
    Lani Hashimoto • Consultant, Patient Experience
    Hashimoto Consulting Services, United States
  • Sabine Haubenreisser, PhD, MSc
    Sabine Haubenreisser, PhD, MSc • Principal Scientific Administrator, Stakeholders and Communication Division
    European Medicines Agency, Netherlands
  • Cammilla Horta Gomes, MA, MPharm
    Cammilla Horta Gomes, MA, MPharm • Latam Regulatory Policy Lead
    Roche, Brazil
  • Stacy Hurt, MBA, MHA
    Stacy Hurt, MBA, MHA • Chief Patient Officer
    Parexel, United States
  • Huong Huynh, PhD
    Huong Huynh, PhD • Director of Regulatory Science
    Critical Path Institute, United States
  • Yatika Kohli, PhD, MBA
    Yatika Kohli, PhD, MBA • Chief Compliance and Strategy Officer
    NoNO Inc, Canada
  • Dominique Lagrave, PharmD
    Dominique Lagrave, PharmD • Chief Regulatory Officer
    Accumulus Technologies, United States
  • Elizabeth Lange, MPH, MS
    Elizabeth Lange, MPH, MS • Executive Director/ Head of Regulatory Scientific Policy
    EMD Serono, United States
  • Jingyu (Julia) Luan, PhD
    Jingyu (Julia) Luan, PhD • Executive Regulatory Science Director, BioPharmaceuticals R&D
    AstraZeneca, United States
  • Demetra Macheras, MBA
    Demetra Macheras, MBA • Director, Regulatory Policy and Intelligence - Regulatory Affairs
    AbbVie, United States
  • David Meats
    David Meats • Director, Regulatory Services & Medical Affairs Management
    Certara, United States
  • Timothe Menard, PharmD, MSc
    Timothe Menard, PharmD, MSc • Global Head, Quality Excellence Digital | Bioethics Ambassador
    F. Hoffmann-La Roche Ltd, Switzerland
  • Pallavi Mishra-Kalyani, PhD, MS
    Pallavi Mishra-Kalyani, PhD, MS • Deputy Division Director, DBV, OB, CDER
    FDA, United States
  • May F Mo, MBA, MS
    May F Mo, MBA, MS • Executive Director, Biostatistics
    Amgen, United States
  • Monica Munoz, PharmD, PhD
    Monica Munoz, PharmD, PhD • Division Director, Division of Pharmacovigilance-I, OSE, CDER
    FDA, United States
  • Lauren Oliva, PharmD, RPh
    Lauren Oliva, PharmD, RPh • US Regulatory Policy Lead
    Biogen, United States
  • Representative Invited
    Representative Invited • FDA, United States
  • Vada Perkins, DrSc, MSc
    Vada Perkins, DrSc, MSc • Vice President, Global Head of Regulatory Intelligence & Policy
    Boehringer Ingelheim, United States
  • Regina Lynn Preciado
    Regina Lynn Preciado • VP, Content Strategy Solutions
    Content Rules, Inc., United States
  • Ranjini Prithviraj, PhD, PMP
    Ranjini Prithviraj, PhD, PMP • Director, Global Medical Affairs, Publication Management
    Regeneron, United States
  • Kim Ribeiro, MS
    Kim Ribeiro, MS • Director Patient Experience & Engagement
    Boehringer Ingelheim, United States
  • Leslie Sam
    Leslie Sam • President
    Leslie Sam and Associates, LLC, United States
  • Earl Seltzer, MBA
    Earl Seltzer, MBA • Senior Director, Partnerships and Innovation
    CTI, United States
  • Anjali Shah, PharmD
    Anjali Shah, PharmD • Executive Director, Business Capabilities and Innovation, WWPS
    Bristol-Myers Squibb Company, United States
  • Nancy Pire Smerkanich, DrSc, MS
    Nancy Pire Smerkanich, DrSc, MS • Assistant Professor Regulatory & Quality Sciences
    University of Southern California School of Pharmacy, United States
  • Cary Smithson, MBA
    Cary Smithson, MBA • Managing Partner
    LeapAhead Solutions, Inc., United States
  • Benjamin Stevens, PhD, MPH
    Benjamin Stevens, PhD, MPH • Director CMC Policy and Advocacy
    GlaxoSmithKline, United States
  • Nancy Linda Styple
    Nancy Linda Styple • Project Management Leader
    Bayer AG, United States
  • Ling Su, PhD
    Ling Su, PhD • Research Fellow
    Yeehong Business School, China
  • John Z. Sun, PhD, MBA, PMP
    John Z. Sun, PhD, MBA, PMP • Program Lead, Global Clinical Operation, Development
    Novartis Pharmaceuticals Corporation, United States
  • Michael Torok, PhD
    Michael Torok, PhD • Vice President, Global Head of Quality Assurance Programs
    Genentech, A Member of the Roche Group, United States
  • Phil Tregunno
    Phil Tregunno • Deputy Director - Patient Safety Monitoring
    Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
  • Representative Invited
    Representative Invited • Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • James Valentine, JD, MHS
    James Valentine, JD, MHS • Director
    Hyman, Phelps & McNamara, PC, United States
  • James Wabby, MHS
    James Wabby, MHS • Global Head, Regulatory Affairs, Emerging Technologies and Combination Products
    AbbVie, United States
  • Paula Walker, MA
    Paula Walker, MA • Global Head of Risk Based Quality Management
    Roche Products Ltd., United Kingdom
  • Robin Whitsell
    Robin Whitsell • President
    Whitsell Innovations, Inc., United States
  • Amira Deia Younes
    Amira Deia Younes • Director-Eastern Europe, Middle East & Africa (EEMEA) Global Regulatory Policy
    MSD, United Arab Emirates
Load More

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表，了解DIA的观点和事件。